EDAP obtains FDA breakthrough status for endometriosis device
The Focal One HIFU system is designed to offer a non-invasive treatment for deep infiltrating endometriosis.
05 March 2024
05 March 2024
The Focal One HIFU system is designed to offer a non-invasive treatment for deep infiltrating endometriosis.
The ALZpath Dx test blood-based test measures levels of phosphorylated tau at position 217 (pTau217) circulating within a patient's system, a typical biomarker of Alzheimer’s Disease.
The BD Vascular Covered Stent is a low-profile, self-expanding, polytetrafluoroethylene encapsulated nitinol implant.
A new study suggests that Japanese patients with chronic conditions score lower than other developed countries across a range of metrics.
The Leva Pelvic Health System is intended to enhance access to non-invasive treatment for urinary and faecal incontinence.
The Helga AI-GEP tool can detect lesions and tissue irregularities in the colon and the upper gastrointestinal tract.
The results detail how Carthera’s SonoCloud-9 system was able to see one-year overall survival rates increase from 11 months to 14 months in patients post-surgery.
For Rare Disease Day, several panels organised by the FDA discussed the importance overcoming accessibility barriers during drug development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.